A critical advance in cancer study is occurring with the use of VHH fragments to reactivate mutated p53. This crucial cancer inhibitor protein is frequently inactivated in many types of cancer, leading uncontrolled https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research